Sunrakshakk Targets INR1,000cr Revenue by FY28 Amid Input-Cost Normalization

Sunrakshakk Industries India Limited — Q1 FY27 Earnings Call (ended 30 Jun 2026)

1. Overall Tone of Management: Optimistic

• Management called Q1 “the strongest quarter in Sunrakshakk’s history” and repeatedly emphasized “strong broad-based demand” and confidence in navigating macro volatility.
• They reaffirmed medium-term targets (INR1,000 cr by FY28) and guided improvement in profitability (“expect to normalize” input-cost pressure; “profit margin… improved” and “get improved by additional 0.75% to 1% in FY’28”).

2. Key Themes from Management Commentary

• FMCG pivot is now dominant and scaling
• FMCG + FMCG intermediates + edible = ~90.60% of consolidated revenue (vs ~83% in FY26).
• Textile is increasingly described as a drag/less insulated from input volatility.
• Capacity expansion and ramp-up are central to growth
• Commissioned a new soap line at Roorkee adding ~1,700 MTPM.
• Aggregate installed capacity for FMCG + FMCG intermediates: 20,840 tons/month (from 19,640 in Q4 FY26).
• Guwahati ramp-up and edible scale-up (Bhilwara) are repeatedly cited as drivers.
• Macro/input-cost volatility acknowledged but framed as temporary
• Geopolitical tension → crude-linked volatility → higher dyes/chemicals/consumables/fuel and PP packaging spikes.
• Management expects normalization “by Q3 or Q4” / “over the next couple of quarters.”
• Medium-term growth + profitability targets reiterated
• INR1,000 crores revenue by FY28; CAGR 32%–35% (FY25–FY29).
• Profitability: expects FY27 to close around ~6% and improve +0.75% to 1% in FY28 (PAT/profitability framing).

3. Q&A Analysis

Theme A: Input costs / crude-linked volatility outlook

• Core question(s):
• How did raw material and crude-linked input costs behave in Q1, and what’s the outlook for the next couple of quarters?
• Through which channels did geopolitics affect the business (inputs, packaging, supply chain)?
• Management response:
• Textile business was “majorly impacted” (dyes, chemicals, fuel/boiler consumables).
• Packaging: PP spike increased packing costs.
• Outlook: normalization expected “by Q3 or Q4” (and also “over the next couple of quarters”).
• Assessment (evasive/strong/partial):
• Mostly specific on channels (LABSA, LABSA-linked chemicals, PP packaging), but no quantified cost impact or hedging/price pass-through detail beyond “couldn’t increase prices” in the prior quarter.

Theme B: FY27 performance expectations (revenue/PAT) + margin trajectory

• Core question(s):
• Expected PAT and turnover for current FY vs expectations for next FY.
• Capacity utilization and whether margins will hold/improve.
• Management response:
• FY27 revenue expected to close between INR900–INR1,000 cr.
• FY27 profitability expected around ~6%, improving +0.75% to 1% in FY28.
• Capex: “majority… completed”; limited investments to balance production lines.
• Capacity utilization: currently ~50%–55%; expects +25%–30% utilization by FY28.
• Assessment:
• Clear quantitative ranges for revenue and profitability, but no explicit linkage to consolidated vs segment margins (some answers mix EBITDA margin vs “profitability” broadly).

Theme C: Capacity utilization, headroom, and capex discipline

• Core question(s):
• Why expand soap line at Roorkee vs new location?
• Current utilization level and near-term headroom.
• Management response:
• Roorkee expansion chosen to reduce civil/investment and because it serves “almost every customer from that location.”
• Utilization: ~50%–55% now; near-term growth supported by ramp-up; no major capacity addition in next 1–1.5 years.
• Assessment:
• Strong operational rationale; headroom quantified via utilization and expected utilization increase.

Theme D: Working capital / capital allocation / fundraising use

• Core question(s):
• Working capital stance (reduce/optimize?).
• Deployment of raised funds; any additional fundraising plans.
• Management response:
• Working capital: “already… balanced”; optimize if scope arises.
• Fund usage: INR98.65 cr preferential issue clarified as not used for acquiring Sunrakshakk Agro (acquisition happened before fundraising).
• Capex deployment: majorly for Bhilwara food manufacturing facility and Guwahati soap/noodle & cosmetics.
• No additional fundraising planned.
• Assessment:
• Good clarification on fund allocation timing (reduces prior ambiguity), but still limited detail on ROI/returns on capital.

Theme E: Textile segment outlook + demerger possibility

• Core question(s):
• Whether textile continues; any demerger plans.
• When textile profitability improves.
• Management response:
• No demerger planned.
• Textile “not good” recently, but by Q3 this year they expect textile to improve.
• Assessment:
• “By Q3” is a time-bound promise but not backed with KPIs; could be a narrative hedge given earlier input-cost explanations.

Theme F: Edible segment progress (Bhilwara) and customer acceptance

• Core question(s):
• Update on savories/spices capacity and utilization.
• Customer acceptance/repeat orders.
• Management response:
• Bhilwara runs one shift, with second shift free if needed.
• B2B model: customers pass testing; “long-term commitment,” with firm orders for next month and quarterly planning.
• Assessment:
• Strong qualitative evidence of customer stickiness; no hard utilization % or capacity numbers provided.

Theme G: Sustainability of margins / steady-state EBITDA

• Core question(s):
• Is the current consolidated EBITDA margin sustainable for 2–3 years?
• Management response:
• “Current quarter number will go up definitely.”
• Target: aim for 7% by FY28, implying EBITDA margin improvement of “another 2% to 2.5%.”
• Assessment:
• This is directionally strong but methodologically unclear (EBITDA vs PAT vs “profitability” conflation; “2% to 2.5%” not clearly defined as points vs percent).

Theme H: Revenue mix and segment contribution

• Core question(s):
• Long-term revenue mix between FMCG and FMCG intermediates vs textile.
• Which segments drive incremental revenue over next 2 years.
• B2B vs B2C and brand plans.
• Management response:
• Long term: textile 8%–10%, FMCG 90%–92%.
• Incremental revenue: food + soap expected higher over next two years.
• B2B only currently; “not into B2C segment.”
• Brand acquisition/own brand: open to acquisitions if “lucrative,” but no current plan for new manufacturing facility acquisitions; developing new products within existing capacity.
• Assessment:
• Consistent B2B stance; “open to acquisitions” remains a recurring but non-committal lever.

4. Guidance / Outlook

Explicit guidance (quantitative)

• Revenue
• FY27 revenue expected to close: INR900–INR1,000 crores
• Medium-term: INR1,000 crores by FY28
• CAGR aspiration: 32%–35% between FY25 and FY29
• Profitability
• FY27 “profitability” expected to close around ~6%
• FY28 improvement: +0.75% to 1% (management phrased as additional improvement in FY28)
• Capacity utilization
• Current utilization: ~50%–55%
• By FY28: expect +25%–30% utilization
• Capex / capacity additions
• “Nothing much is expected” for capacity addition in next 1–1.5 years
• Segment mix
• Long-term: textile 8%–10%, FMCG 90%–92%

Implicit signals (qualitative)

• Input-cost normalization expected by Q3/Q4 → margin pressure should ease.
• Margin improvement is primarily tied to scale/operating leverage and capacity utilization ramp-up, not major pricing power claims.
• Management is capital disciplined (no additional fundraising planned; capex largely done).

5. Standout Statements (direct / high-signal)

• “Q1 FY’27 has been the strongest quarter in Sunrakshakk’s history.”
• FMCG mix shift: FMCG/FMCG intermediate/edible now contribute “approximately 90.60% of our consolidated revenue” (up from ~83% in FY26).
• Capacity: “commissioned a new soap production line… adding approximately 1,700 metric ton of monthly capacity.”
• Macro normalization expectation: “we believe that by Q3 or Q4 things will get normalized.”
• FY27 revenue expectation: “closing somewhere in between the INR900 crores to INR1,000 crores mark.”
• Profitability: “this year… we expect… around 6%… improved by additional 0.75% to 1% in FY’28.”
• Capex discipline: “majority of the expansion or capacity increase activities had been completed… Nothing much is expected out in next one, one and a half year…”
• Textile stance: “we don’t have any plan for demerger.”
• B2B only: “As of now, we are not into the B2C segment.”
• Margin sustainability claim: “the current quarter number will go up definitely in the future” and “aiming a target of 7% by FY’28.”

6. Red Flags / Positive Signals

Positive signals
– Clear operational actions tied to results: new Roorkee line commissioned; utilization ramp-up plan.
– Management provides multiple quantitative anchors (revenue range, utilization range, profitability targets).
– Fund allocation clarified (INR98.65 cr not used for Agro acquisition; used for Bhilwara + Guwahati facilities).

Red flags
– Margin metrics ambiguity: “profitability” vs EBITDA vs PAT targets sometimes blur; “2% to 2.5%” improvement is not clearly defined.
– Normalization language (“Q3/Q4”, “next couple of quarters”) without quantified sensitivity to crude/inputs.
– Textile improvement is promised “by Q3 this year” but textile is repeatedly described as impacted by input volatility—risk that improvement depends on macro easing rather than structural fixes.
– Repeated “open to acquisitions if lucrative” without specifics (could be a narrative fallback).

7. Historical Comparison & Consistency Analysis (vs prior calls)

a. Change in Tone Over Time

• Current call (Q1 FY27): More Optimistic
• Strongest-quarter framing; confidence in normalization and margin improvement.
• Prior calls (Q4/FY26 on Jun 3 2026): Optimistic but more cautious on margins
• Q4 FY26 emphasized operating leverage and improved profitability, but FY26 full-year EBITDA margin was 9.66% (down from 14.24% in FY25), indicating margin pressure despite growth.
• Shift drivers
• Q1 FY27 adds a new capacity line and provides utilization ramp-up numbers (50–55% now; +25–30% by FY28), making the optimism more “execution-based” than purely narrative.

b. Tracking Past Commitments vs Outcomes

• Past statement (Jun 3 2026 call): “target of achieving INR1,000 crores revenue by FY28” and “can be achieved with existing capacity” (no major capex required).
• What was expected: INR1,000 cr by FY28 without heavy additional capex.
• What happened / current call evidence:
• Current call still targets INR1,000 cr by FY28, but now explicitly references commissioning new Roorkee soap line and ongoing ramp-up—still consistent with “existing capacity” logic, but it’s not purely “no capex”; there has been continued capacity build.

• Status: ✅ Mostly delivered / consistent on the target; ⏳ Nuanced on “no capex” (capex/capacity additions continued into FY27).

• Past statement (Jun 3 2026 call): PAT margin target “aiming for a PAT of 7%” in near future.

• Current call: FY27 profitability expected ~6%, improving +0.75% to 1% in FY28; also “aiming target of 7% by FY’28.”

• Status: ✅ On track (target timing aligns better with FY28 than FY27).

• Past statement (Feb 16 2026 call): FMCG contribution expected to rise materially (management earlier suggested FMCG could reach ~95% long run).

• Current call: FMCG/FMCG intermediates/edible now ~90.60% of revenue; textile expected 8%–10% long term.
• Status: ✅ Consistent trajectory.

c. Narrative Shifts

• Textile narrative becomes more “temporary drag”
• Feb/Jun calls framed textile as shrinking share; Q1 FY27 adds a clearer “input-cost sensitivity” explanation and promises normalization by Q3/Q4.
• Margin narrative shifts from “mix-driven” to “cost normalization + utilization ramp”
• Q1 FY27 attributes consolidated EBITDA margin moderation to raw material cost and expects normalization; prior calls emphasized mix and operating leverage.

d. Consistency & Credibility Signals

• Medium credibility
• Strength: repeated quantitative targets (INR1,000 cr; utilization ramp; profitability improvement).
• Weakness: margin metric clarity issues and reliance on macro normalization timing (“Q3/Q4”) without quantification.
• No major contradiction on core strategy (FMCG pivot, B2B model, FY28 revenue target), but some answers remain broad.

e. Evolution of Key Themes

• Demand: Improving/strong broad-based demand continues (consistent).
• Margins: Consolidated margin shows moderation in Q1 due to inputs; management expects recovery via normalization + scale (mixed/stable).
• Expansion: Continued capacity additions (Roorkee line) but with a message that major capex is largely done (stabilizing).
• Macro risk: Becomes more explicit in Q1 (geopolitical tension, PP packaging spike, LABSA-linked chemicals).

f. Additional Insights (cross-period)

• The company’s growth appears increasingly capacity-ramp dependent (utilization targets and “no major capex next 1–1.5 years”), which can be positive for predictability but also increases risk if demand or ramp timing slips.
• Management’s margin recovery thesis is increasingly tied to normalization of input costs—a macro-dependent lever—rather than purely operational improvements.